Center Laboratories, Inc. (4123.TWO)
TWD 41.9
(-1.53%)
TWD 41.9
(-1.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 27 Billion TWD | 7.2% |
| 2022 | 25.18 Billion TWD | -17.26% |
| 2021 | 30.44 Billion TWD | 9.25% |
| 2020 | 27.86 Billion TWD | 21.87% |
| 2019 | 22.86 Billion TWD | 12.21% |
| 2018 | 20.37 Billion TWD | -46.8% |
| 2017 | 38.29 Billion TWD | 26.17% |
| 2016 | 30.35 Billion TWD | 8.75% |
| 2015 | 27.91 Billion TWD | 190.27% |
| 2014 | 9.61 Billion TWD | 75.97% |
| 2013 | 5.46 Billion TWD | 34.03% |
| 2012 | 4.07 Billion TWD | 56.1% |
| 2011 | 2.61 Billion TWD | 6.55% |
| 2010 | 2.45 Billion TWD | 1.5% |
| 2009 | 2.41 Billion TWD | 137.67% |
| 2008 | 1.01 Billion TWD | 56.62% |
| 2007 | 648.83 Million TWD | 30.92% |
| 2006 | 495.58 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 27.09 Billion TWD | 0.33% |
| 2024 Q2 | 27.04 Billion TWD | -0.15% |
| 2023 Q1 | 27.71 Billion TWD | 10.02% |
| 2023 Q3 | 27.01 Billion TWD | -2.25% |
| 2023 Q4 | 27 Billion TWD | -0.05% |
| 2023 FY | 27 Billion TWD | 7.2% |
| 2023 Q2 | 27.63 Billion TWD | -0.27% |
| 2022 Q2 | 26.2 Billion TWD | -10.54% |
| 2022 Q4 | 25.18 Billion TWD | -3.27% |
| 2022 FY | 25.18 Billion TWD | -17.26% |
| 2022 Q1 | 29.29 Billion TWD | -3.77% |
| 2022 Q3 | 26.04 Billion TWD | -0.64% |
| 2021 Q4 | 30.44 Billion TWD | -6.05% |
| 2021 FY | 30.44 Billion TWD | 9.25% |
| 2021 Q1 | 31.99 Billion TWD | 14.83% |
| 2021 Q2 | 34.37 Billion TWD | 7.44% |
| 2021 Q3 | 32.4 Billion TWD | -5.74% |
| 2020 Q3 | 24.83 Billion TWD | 12.21% |
| 2020 Q4 | 27.86 Billion TWD | 12.2% |
| 2020 Q2 | 22.13 Billion TWD | -1.35% |
| 2020 Q1 | 22.43 Billion TWD | -1.86% |
| 2020 FY | 27.86 Billion TWD | 21.87% |
| 2019 FY | 22.86 Billion TWD | 12.21% |
| 2019 Q3 | 22.24 Billion TWD | -12.25% |
| 2019 Q2 | 25.35 Billion TWD | 20.57% |
| 2019 Q1 | 21.02 Billion TWD | 3.2% |
| 2019 Q4 | 22.86 Billion TWD | 2.77% |
| 2018 Q2 | 41.68 Billion TWD | 0.59% |
| 2018 Q1 | 41.44 Billion TWD | 8.21% |
| 2018 FY | 20.37 Billion TWD | -46.8% |
| 2018 Q4 | 20.37 Billion TWD | -50.69% |
| 2018 Q3 | 41.32 Billion TWD | -0.87% |
| 2017 Q3 | 36.11 Billion TWD | 5.93% |
| 2017 Q2 | 34.09 Billion TWD | 10.69% |
| 2017 Q1 | 30.8 Billion TWD | 1.48% |
| 2017 FY | 38.29 Billion TWD | 26.17% |
| 2017 Q4 | 38.29 Billion TWD | 6.04% |
| 2016 Q3 | 30.66 Billion TWD | 2.78% |
| 2016 FY | 30.35 Billion TWD | 8.75% |
| 2016 Q1 | 29.18 Billion TWD | 4.56% |
| 2016 Q2 | 29.83 Billion TWD | 2.21% |
| 2016 Q4 | 30.35 Billion TWD | -1.0% |
| 2015 Q4 | 27.91 Billion TWD | 4.88% |
| 2015 FY | 27.91 Billion TWD | 190.27% |
| 2015 Q3 | 26.61 Billion TWD | 111.82% |
| 2015 Q2 | 12.56 Billion TWD | 24.27% |
| 2015 Q1 | 10.11 Billion TWD | 5.14% |
| 2014 Q1 | 5.93 Billion TWD | 8.55% |
| 2014 FY | 9.61 Billion TWD | 75.97% |
| 2014 Q4 | 9.61 Billion TWD | 20.15% |
| 2014 Q3 | 8 Billion TWD | 20.82% |
| 2014 Q2 | 6.62 Billion TWD | 11.66% |
| 2013 Q2 | 4.14 Billion TWD | -3.05% |
| 2013 Q3 | 5.68 Billion TWD | 37.09% |
| 2013 FY | 5.46 Billion TWD | 34.03% |
| 2013 Q4 | 5.46 Billion TWD | -3.94% |
| 2013 Q1 | 4.28 Billion TWD | 4.98% |
| 2012 Q2 | 2.69 Billion TWD | -2.31% |
| 2012 Q4 | 4.07 Billion TWD | -1.94% |
| 2012 Q3 | 4.15 Billion TWD | 54.17% |
| 2012 Q1 | 2.76 Billion TWD | 5.69% |
| 2012 FY | 4.07 Billion TWD | 56.1% |
| 2011 Q3 | 2.49 Billion TWD | -3.07% |
| 2011 Q1 | 2.55 Billion TWD | 4.43% |
| 2011 Q2 | 2.57 Billion TWD | 0.42% |
| 2011 Q4 | 2.61 Billion TWD | 4.82% |
| 2011 FY | 2.61 Billion TWD | 6.55% |
| 2010 FY | 2.45 Billion TWD | 1.5% |
| 2010 Q4 | 2.45 Billion TWD | 0.0% |
| 2009 FY | 2.41 Billion TWD | 137.67% |
| 2008 FY | 1.01 Billion TWD | 56.62% |
| 2007 FY | 648.83 Million TWD | 30.92% |
| 2006 FY | 495.58 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Allied Biotech Corporation | 2.07 Billion TWD | -1198.865% |
| GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -2197.323% |
| Easywell Biomedicals, Inc. | 1.21 Billion TWD | -2124.626% |
| TTY Biopharm Company Limited | 9.87 Billion TWD | -173.442% |
| Synmosa Biopharma Corporation | 11.72 Billion TWD | -130.225% |
| Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | -149.747% |
| Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -4028.549% |
| Orient Pharma Co., Ltd. | 2.56 Billion TWD | -953.671% |
| InnoPharmax Inc. | 524.19 Million TWD | -5051.156% |
| Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -1254.889% |
| Excelsior Biopharma Inc. | 1.57 Billion TWD | -1611.892% |
| DV Biomed Co., Ltd. | 1.81 Billion TWD | -1389.654% |
| Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -1350.603% |
| Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | -789.051% |
| UniPharma Co., Ltd. | 350.07 Million TWD | -7613.271% |
| Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | -1117.095% |
| Alar Pharmaceuticals Inc. | 973.2 Million TWD | -2674.557% |
| Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -3267.793% |
| Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -6063.82% |
| Bioray Biotech Co., Ltd | 542.64 Million TWD | -4875.998% |
| TSH Biopharm Corporation Limited | 1.39 Billion TWD | -1828.92% |